Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda

Fri, 30th Jul 2021 09:50

(Alliance News) - The following London-listed shares received analyst recommendations Friday and Thursday:

----------

FTSE 100

----------

JEFFERIES RAISES SEGRO PRICE TARGET TO 1,100 (999) PENCE - 'HOLD'

----------

BARCLAYS RAISES SCHRODERS PRICE TARGET TO 3,675 (3,550) PENCE - 'EQUAL WEIGHT'

----------

DEUTSCHE BANK RAISES ST JAMES'S PLACE PRICE TARGET TO 1,770 (1,620) PENCE - 'BUY'

----------

BARCLAYS RAISES INTERMEDIATE CAPITAL TARGET TO 2,260 (2,145) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES INTERMEDIATE CAPITAL TARGET TO 2,600 (2,560) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ADMIRAL GROUP PRICE TARGET TO 2,730 (2,500) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES LLOYDS PRICE TARGET TO 57 (56) PENCE - 'BUY'

----------

JPMORGAN RAISES LLOYDS PRICE TARGET TO 60 (59) PENCE - 'OVERWEIGHT

----------

SOCGEN RAISES BAE SYSTEMS PRICE TARGET TO 660 (614) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS INTERTEK PRICE TARGET TO 5,790 (6,310) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES RELX PRICE TARGET TO 2,300 (2,050) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES RELX PRICE TARGET TO 2,390 (2,235) PENCE - 'OVERWEIGHT'

----------

UBS RAISES RELX PRICE TARGET TO 2,040 (1,940) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES SAGE GROUP PRICE TARGET TO 720 (630) PENCE - 'NEUTRAL'

----------

CANACCORD CUTS SAGE GROUP TO 'HOLD' ('BUY')

----------

RBC RAISES RENTOKIL INITIAL PRICE TARGET TO 645 (625) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES RENTOKIL INITIAL PRICE TARGET TO 610 (600) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES COMPASS GROUP PRICE TARGET TO 1,740 (1,720) PENCE - 'OVERWEIGHT'

----------

SOCGEN RAISES ITV PRICE TARGET TO 175 (150) PENCE - 'BUY'

----------

JPMORGAN RAISES BT GROUP PRICE TARGET TO 235 (225) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES NEXT TO 'NEUTRAL' ('UNDERPERFORM') TARGET 8,025 (7,150) PENCE

----------

JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1,579 (1,542) PENCE - 'NEUTRAL''

----------

BERENBERG RAISES DIAGEO PRICE TARGET TO 3,700 (3,540) PENCE - 'HOLD'

----------

CREDIT SUISSE RAISES DIAGEO PRICE TARGET TO 3,950 (3,700) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES DIAGEO PRICE TARGET TO 4,000 (3,800) PENCE - 'BUY'

----------

BARCLAYS RAISES DIAGEO PRICE TARGET TO 4,000 (3,940) PENCE - 'OVERWEIGHT'

----------

RBC RAISES DIAGEO PRICE TARGET TO 2,800 (2,700) PENCE - 'SECTOR PERFORM'

----------

DZ BANK RAISES FAIR VALUE FOR GLAXOSMITHKLINE TO 1,600 (1,510) PENCE - 'BUY'

----------

BARCLAYS RAISES CRODA TO 'EQUAL WEIGHT' (UNDERWEIGHT) - PRICE TARGET 8,400 (6,000)

PENCE

----------

CREDIT SUISSE RAISES CRODA PRICE TARGET TO 8,900 (7,200) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES ANGLO AMERICAN PRICE TARGET TO 3,700 (3,600) PENCE - 'BUY'

----------

DZ BANK RAISES FAIR VALUE FOR RIO TINTO TO 7,440 (6,850) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES EVRAZ PRICE TARGET TO 600 (580) PENCE - 'SELL'

----------

DZ BANK RAISES ROYAL DUTCH SHELL TO 'BUY' (HOLD)

----------

BERENBERG RAISES SHELL B PRICE TARGET TO 1,720 (1,570) PENCE - 'BUY'

----------

GOLDMAN RAISES SHELL B PRICE TARGET TO 2,260 (2,200) PENCE - 'BUY'

----------

FTSE 250

----------

LIBERUM RAISES SANNE GROUP PRICE TARGET TO 875 (660) PENCE - 'HOLD'

----------

BARCLAYS RAISES SPECTRIS PRICE TARGET TO 3,920 (3,645) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES INCHCAPE PRICE TARGET TO 910 (830) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES BODYCOTE PRICE TARGET TO 800 (675) PENCE - 'UNDERWEIGHT'

----------

RBC RAISES BODYCOTE PRICE TARGET TO 900 (820) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES MORGAN ADVANCED MATERIALS PRICE TARGET TO 375 (350) PENCE - SECTOR PERFORM

----------

JPMORGAN RAISES IMI PRICE TARGET TO 2,050 (1,775) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES COMPUTACENTER PRICE TARGET TO 3,300 (3,000) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES HOWDEN JOINERY GROUP PRICE TARGET TO 1,035 (890) PENCE - 'BUY'

----------

JEFFERIES RAISES IG GROUP PRICE TARGET TO 1,100 (1,050) PENCE - 'BUY'

----------

JPMORGAN RAISES MAN GROUP PRICE TARGET TO 270 (240) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES PARAGON GROUP PRICE TARGET TO 630 (600) PENCE - 'BUY'

----------

LIBERUM RAISES PETS AT HOME PRICE TARGET TO 550 (510) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES YOUGOV PRICE TARGET TO 1,500 (1,200) PENCE - 'BUY'

----------

PEEL HUNT RAISES YOUGOV PRICE TARGET TO 1,480 (1,200) PENCE - 'BUY'

----------

BERENBERG RAISES PENDRAGON PRICE TARGET TO 27 (26) PENCE - 'BUY'

----------

BERENBERG CUTS ANGLO PACIFIC GROUP PRICE TARGET TO 150 (160) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FORTERRA PRICE TARGET TO 340 (320) PENCE - 'BUY'

----------

JEFFERIES RAISES FORTERRA PRICE TARGET TO 326 (307) PENCE - 'HOLD'

----------

BERENBERG RAISES DISCOVERIE PRICE TARGET TO 1,100 (930) PENCE - 'BUY'

----------

JEFFERIES RAISES RIVER & MERCANTILE TO 'BUY' ('HOLD') - TARGET 270 (220) PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.